PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
3.85%
Net income growth under 50% of MCHP's 23.72%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-0.82%
Both reduce yoy D&A, with MCHP at -5.82%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
136.36%
Well above MCHP's 42.62% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
45.24%
SBC growth well above MCHP's 4.18%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-179.62%
Negative yoy working capital usage while MCHP is 221.14%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-672.73%
AR is negative yoy while MCHP is 131.38%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-44.44%
Negative yoy inventory while MCHP is 7.33%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
2200.00%
A yoy AP increase while MCHP is negative at -172.02%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-204.79%
Negative yoy usage while MCHP is 105.68%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
97.80%
Well above MCHP's 55.96%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-12.94%
Negative yoy CFO while MCHP is 35.00%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-45.28%
Negative yoy CapEx while MCHP is 20.17%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-100.00%
Negative yoy acquisition while MCHP stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-18.33%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
26.02%
We have some liquidation growth while MCHP is negative at -104.26%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
91.81%
Growth well above MCHP's 57.96%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-11.35%
We reduce yoy invests while MCHP stands at 52.39%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-10.00%
Both yoy lines negative, with MCHP at -350.20%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
71.93%
We slightly raise equity while MCHP is negative at -45.00%. John Neff sees competitor possibly preserving share count or buying back shares.
-566.67%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.